# Kaitai Capital: portfolio, investments and team

> Kaitai Capital is a vc firm based in China. 76 investments on record, 8 in the last 12 months, latest Aug 2026. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/kaitai-capital (Millionrounds; every figure on the page links to its filing or article)

China · [Investor](https://millionrounds.com/investors)

# Kaitai Capital

Last cheque observed Aug 2026; 76 cheques on record.

Deploying now VC firm

Seed Series A Series B Artificial Intelligence Biotech Life Sciences

Deploying now

**57%** of best year **8** **cheques in 12 months**, 76 on record

Since the last cheque **86** days **00** hrs **00** min **00** sec

Median round **$14M** Rounds led **0 of 76** Sole investor **30 rounds** Mostly in **United States, 83%**

Pitch Kaitai Capital

## Kaitai Capital highlights

- 01 8 cheques in the last 12 months
- 02 Mostly Series A and Venture: 54% of its rounds
- 03 Sole investor in 30 rounds, median $3.0M

## What they do

> Kaitai Capital is a venture capital management institution, primarily engaged in innovative investment management business. Translated from Chinese, from their own website

- **Type:** VC firm
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B
- **Sectors:** Artificial Intelligence Biotech Life Sciences
- **Based in:** Hangzhou, China
- **Cold pitches:** Accepted

## The record

Every round we can evidence, newest first **76 appearances**

- **2026** 5 rounds
- **Aug** **[Astrocyte Pharmaceuticals](https://millionrounds.com/company/astrocyte-pharmaceuticals)** Grant · US **$400K** With 2 others
- **Mar** **[Deep Intelligent Pharma](https://millionrounds.com/company/deep-intelligent-pharma)** Venture · SG **$40M** With 3 others
- **Mar** **[PaXini Tech](https://millionrounds.com/company/paxini-tech)** Series B **$145M** With 1 other
- **Feb** **[West Lake Xinchen](https://millionrounds.com/company/west-lake-xinchen)** Seed **$15M** With 2 others
- **Jan** **[Xihu Xinchen](https://millionrounds.com/company/xihu-xinchen)** Venture **Undisclosed** With 2 others
- **2025** 12 rounds
- **Dec** **[Worg Pharmaceuticals](https://millionrounds.com/company/worg-pharmaceuticals)** Series D **$43M** With 2 others
- **Dec** **[Levinthal](https://millionrounds.com/company/levinthal)** Venture **Undisclosed** With 1 other
- **Nov** **[Junsai Shengwu](https://millionrounds.com/company/junsai-shengwu)** Series C **$19M** With 1 other
- **Oct** **[OncoC4](https://millionrounds.com/company/oncoc4)** Series B · US **$50M** With 1 other
- **Oct** **[BridGene Biosciences](https://millionrounds.com/company/bridgene-biosciences)** Series B · US **$28M** Sole investor
- **Sept** **[Youxin Cloud](https://millionrounds.com/company/youxin-cloud)** **$6.0M** With 2 others
- **Aug** **[Huaboron Neutron](https://millionrounds.com/company/huaboron-neutron)** Venture **Undisclosed** With 1 other
- **Aug** **[Pleryon Therapeutics](https://millionrounds.com/company/pleryon-therapeutics)** Venture **Undisclosed** Sole investor
- **Aug** **[Minova Pharma](https://millionrounds.com/company/minova-pharma)** Series B **$14M** With 2 others
- **Jul** **[Xinbele Bio](https://millionrounds.com/company/xinbele-bio)** Venture **Undisclosed** Sole investor
- **Mar** **[Chance Pharmaceuticals](https://millionrounds.com/company/chance-pharmaceuticals)** Venture **Undisclosed** With 1 other
- **Jan** **[Bivision](https://millionrounds.com/company/bivision)** Series A **$14M** With 2 others
- **2024** 4 rounds
- **Dec** **[Ruixun Biotech](https://millionrounds.com/company/ruixun-biotech)** Venture **Undisclosed** With 1 other
- **May** **[Xinyue](https://millionrounds.com/company/xinyue)** Series A **$1.4M** With 3 others
- **Jan** **[TechnoDerma Medicines](https://millionrounds.com/company/technoderma-medicines)** Venture **Undisclosed** With 1 other
- **Jan** **[Phanes Therapeutics](https://millionrounds.com/company/phanes-therapeutics)** Venture · US **Undisclosed** With 2 others
- **2023** 8 rounds
- **Dec** **[Ceram Pharmaceuticals](https://millionrounds.com/company/ceram-pharmaceuticals)** Series A **$14M** With 2 others
- **Oct** **[Atom Bioscience & Pharmaceutical](https://millionrounds.com/company/atom-bioscience-and-pharmaceutical)** Series D **$82M** With 3 others
- **Sept** **[Nafi Pharmaceuticals](https://millionrounds.com/company/nafi-pharmaceuticals)** Venture **Undisclosed** Sole investor
- **Aug** **[Circular Code Biology](https://millionrounds.com/company/circular-code-biology)** Venture **Undisclosed** With 1 other
- **Aug** **[Astrocyte Pharmaceuticals](https://millionrounds.com/company/astrocyte-pharmaceuticals)** Series B · US · Firms' own news pages **$6.0M** With 10 others
- **Aug** **[CirCode](https://millionrounds.com/company/circode)** Venture **Undisclosed** With 1 other
- **May** **[Hongyun Biotech](https://millionrounds.com/company/hongyun-biotech)** Series B **$14M** With 1 other
- **Apr** **[Databaker](https://millionrounds.com/company/databaker)** Series B **$15M** With 1 other
- **2022** 11 rounds
- **Nov** **[Lupeng Pharmaceutical](https://millionrounds.com/company/lupeng-pharmaceutical)** Series A **$35M** With 3 others
- **Nov** **[Primelink Bio](https://millionrounds.com/company/primelink-bio)** Venture **$14M** With 2 others
- **Sept** **[Realibox](https://millionrounds.com/company/realibox)** Series A **$14M** With 2 others
- **Aug** **[Aoquan](https://millionrounds.com/company/aoquan)** Series B **$15M** Sole investor
- **Jul** **[Apache DolphinScheduler](https://millionrounds.com/company/apache-dolphinscheduler)** Pre-seed **$10M** Sole investor
- **Jul** **[Wangfanxin](https://millionrounds.com/company/wangfanxin)** Series A **$15M** With 2 others
- **Jun** **[Yiwise](https://millionrounds.com/company/yiwise)** Venture **Undisclosed** With 4 others
- **Apr** **[Worktile](https://millionrounds.com/company/worktile)** Series C **$15M** With 1 other
- **Apr** **[Ke Ning Bio](https://millionrounds.com/company/ke-ning-bio)** Seed **$16M** Sole investor
- **Feb** **[TaoCloud](https://millionrounds.com/company/taocloud)** Series C **$866K** Sole investor
- **Jan** **[Bichen Pharmaceutical](https://millionrounds.com/company/bichen-pharmaceutical)** Series B **$30M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **1** person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## The cheque

Seed Series A Series B

Median round joined **$14M** the round, not its cheque Alone, median **$3.0M**

Led 0 of 76 rounds **0%**

- **Sole investor:** 30 rounds
- **Last cheque:** Aug 2026

Rounds by stage said on their site

- Series A said *21*
- Venture *18*
- Series B said *16*
- Seed said *6*
- Pre-seed *6*
- Series C *5*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [CDH Investments](https://millionrounds.com/fund/cdh-investments) 3
- [Fortune Venture Capital](https://millionrounds.com/fund/fortune-capital) 3
- [GSR](https://millionrounds.com/fund/gsr) 3
- [GSR United Capital](https://millionrounds.com/fund/gsr-united-capital) 3
- [HSG](https://millionrounds.com/fund/hsg) 3
- [ZhenFund](https://millionrounds.com/fund/zhenfund) 3

**Pitching Kaitai Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Kaitai Capital. A count of rooms they were both in, not a relationship either has claimed.

[**CDH Investments** Private equity **3** rounds together](https://millionrounds.com/fund/cdh-investments)[**Fortune Venture Capital** VC firm **3** rounds together](https://millionrounds.com/fund/fortune-capital)[**GSR** VC firm **3** rounds together](https://millionrounds.com/fund/gsr)[**GSR United Capital** VC firm **3** rounds together](https://millionrounds.com/fund/gsr-united-capital)[**HSG** VC firm **3** rounds together](https://millionrounds.com/fund/hsg)[**ZhenFund** VC firm **3** rounds together](https://millionrounds.com/fund/zhenfund)[**Baidu Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/baidu-ventures)[**BlueRun Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/bluerun-ventures)[**Cathay Capital** Private equity **2** rounds together](https://millionrounds.com/fund/cathay-capital)[**DeepWork Capital** VC firm **2** rounds together](https://millionrounds.com/fund/deepwork-capital)[**Hill House Capital** Family office **2** rounds together](https://millionrounds.com/fund/hill-house-capital)[**K2VC** VC firm **2** rounds together](https://millionrounds.com/fund/k2vc)

## Recently backed

The latest companies Kaitai Capital put money into.

[**Astrocyte Pharmaceuticals** $400K · Aug 2026](https://millionrounds.com/company/astrocyte-pharmaceuticals)[**Deep Intelligent Pharma** $40M · Mar 2026](https://millionrounds.com/company/deep-intelligent-pharma)[**PaXini Tech** $145M · Mar 2026](https://millionrounds.com/company/paxini-tech)[**Levinthal** Dec 2025](https://millionrounds.com/company/levinthal)[**BridGene Biosciences** $28M · Oct 2025](https://millionrounds.com/company/bridgene-biosciences)[**Pleryon Therapeutics** Aug 2025](https://millionrounds.com/company/pleryon-therapeutics)

## Quick answers about Kaitai Capital

### What does Kaitai Capital invest in?

Kaitai Capital invests most often at Series A and Venture (54% of the rounds on record), in sectors such as Artificial Intelligence, Biotech and Life Sciences.

### How active is Kaitai Capital?

76 investments on record, 8 of them in the last 12 months. The most recent was in Aug 2026.

### What has Kaitai Capital invested in recently?

Its most recent investments on record: Astrocyte Pharmaceuticals (Grant, Aug 2026), Deep Intelligent Pharma (Venture, Mar 2026) and PaXini Tech (Series B, Mar 2026).

### How big are Kaitai Capital's cheques?

The median round it joins is $14M.

### Does Kaitai Capital lead rounds?

Rarely, if at all: none of its 76 investments on record names it as the lead.

### Where does Kaitai Capital invest?

Most of the companies it backs are in the United States (83%) and Singapore (17%).

### Is Kaitai Capital investing now?

Yes: it is actively investing, with 8 investments in the last 12 months.

### Who does Kaitai Capital invest alongside?

Most often CDH Investments (3 rounds together), Fortune Venture Capital (3 rounds together) and GSR (3 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=kaitai-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=kaitai-capital)